Bang Er Orthopedic
Venture Round in 2023
Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.
Data Grand
Series C in 2022
Data Grand is a provider of text processing technology and intelligent office robot services, specializing in big data application services for various industries. The company offers a comprehensive suite of tools, including a text mining engine, intelligent recommendation systems, and an intelligent knowledge graph. Their advanced technology incorporates natural language understanding and generation, enabling users to efficiently extract, review, and search for information within large databases. Additionally, Data Grand's services encompass document smart review, intelligent search systems, customer opinion insights, optical character recognition, and robotic process automation. By leveraging these innovative solutions, Data Grand aims to enhance business efficiency and improve data mining capabilities for large enterprises.
Grit Science
Series A in 2022
Grit Science is a biotechnology company specializing in gene therapeutics, focusing on the research and development of liver-related genetic treatments. The firm is dedicated to creating innovative medical products that address clinical needs and enhance human health. Through its commitment to advancing biopharmaceutical technology, Grit Science aims to provide effective solutions in the field of genetic medicine.
ChangXin Memory Technologies
Venture Round in 2022
ChangXin Memory Technologies is a Chinese company that specializes in the development, manufacturing, and sales of dynamic random-access memory (DRAM) semiconductor products. It focuses on producing integrated circuits used for data memory and related functions, catering to industry users with low-power data storage solutions. The company is engaged in extensive research and development efforts to enhance its product offerings and maintain competitiveness in the semiconductor sector. Through its commitment to innovation and quality, ChangXin Memory Technologies aims to play a significant role in the global memory market.
Zaihui is a Chinese company founded in 2015 that specializes in providing a SaaS-based data-driven marketing automation solution tailored for local businesses. The company offers a comprehensive platform that includes member management, customer relationship management, and customized marketing strategies supported by big data. Zaihui's services enable local merchants, particularly in the restaurant sector, to enhance operational efficiency through features such as QR code ordering, online payment, and loyalty programs. The platform facilitates intelligent precision marketing, brand packaging, and various promotional activities, empowering small and medium-sized enterprises to establish their unique branding and improve customer engagement.
ImmuneOnco
Series C in 2022
ImmuneOnco Biopharma, founded in June 2015 in Zhangjiang High-Tech Park, Shanghai, is an innovative biopharmaceutical company focused on developing and commercializing novel cancer immunotherapy products. The company aims to reverse immune inhibition caused by cancer cells and actively eliminate these cells. ImmuneOnco is recognized for its systematic approach to leveraging both innate and adaptive immune systems in its research and development efforts. The company boasts a robust pipeline of 14 drug candidates, with eight currently undergoing clinical programs, highlighting its commitment to advancing immuno-oncology therapies. ImmuneOnco's extensive understanding of cancer biology and immunology enables it to transform scientific research into viable therapeutic options.
XuanZhu Pharma
Series B in 2021
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.
Neurophth Therapeutics
Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.
GeekBang Technology is an online learning platform dedicated to enhancing the skills of digital talents through immersive and in-depth educational experiences. The company operates a global IT knowledge service platform that encompasses a variety of offerings, including media, conferences, training, consulting, and social services. By fostering communities within the technology sector, GeekBang facilitates knowledge transfer among professionals, promoting technological innovation and collaboration. Its diverse channels, such as communities, live broadcasts, and tribes, enable users to engage deeply with content and connect with peers in their field.
Lepu Biotechnology Co., Ltd. is a Chinese biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform dedicated to target discovery, drug preparation, development, and manufacturing. The company focuses on creating drug candidates that include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). Lepu Bio's core products are currently in clinical stages I to III, demonstrating its commitment to advancing cancer treatment through innovative biopharmaceutical solutions.
MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013, the company operates from its headquarters in Yantai, China, and has an additional office in Fremont, California. MabPlex provides a comprehensive range of services that encompass all stages of drug development, from DNA to finished drug products. Its offerings include customized mammalian cell medium, cell banking, and the manufacturing of monoclonal antibody active pharmaceutical ingredients, as well as fill and finish services for biologics and antibody-drug conjugates. The company aims to deliver high-quality solutions for bio-manufacturing to its global partners.
Norson Biotechnology
Series B in 2020
Norson Biotechnology produces edible probiotic powder, probiotic solid beverages, fermented lactic acid bacteria beverages, and other products.
Huisuanzhang
Series C in 2020
Huisuanzhang is a financial services platform established in April 2015, catering to the needs of small and medium-sized enterprises (SMEs) in China. The company offers a range of services, including bookkeeping, invoicing, tax planning, accounting, business registration, and trademark registration, all designed to streamline financial operations for integrated enterprises. Utilizing cloud and mobile Internet technologies, Huisuanzhang delivers affordable and efficient financial services across a broad network that covers over 200 cities in China, bolstered by more than 300 regional service agencies. With a focus on innovation and user experience, the company continuously enhances its service offerings to address the specific challenges faced by SMEs. As of September 2017, Huisuanzhang's reach extends to over 230,000 business users, establishing itself as a key player in providing comprehensive financial and tax solutions within the Chinese market.
Beijing Sinoiov Information Technology Co., Ltd. is a data technology company specializing in logistics solutions tailored for the road freight industry. The company focuses on facilitating digital transformation by leveraging artificial intelligence to enhance operational efficiency and reduce costs for logistics customers. Sinoiov has developed a comprehensive freight vehicle monitoring platform that integrates GPS monitoring, intelligent dispatching, and big data analysis, enabling logistics and freight companies to optimize their operations. With a strong network infrastructure, Sinoiov operates national vehicle networking industrial bases in Beijing and Chongqing and has established over 40 provincial branches across China, thus supporting a wide range of services that promote the digital, internet, and intelligent transformation of the road freight sector.
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.
ECheng (e成) is a B2B SaaS platform that provides HR matching and resume screening for enterprises. Using machine learning, data mining, and NLP (natural language processing), the company categorizes resumes that best fit the job requirements of the client company. The company was launched in 2013 by industry veterans from Baidu, IBM, and Microsoft, serving multinational conglomerates as well as small and medium-sized companies.
Zhihu is a prominent Chinese social question-and-answer platform that allows users to seek information by soliciting opinions and insights from individuals rather than relying solely on traditional forum responses. Established to foster a community-driven exchange of knowledge, Zhihu has grown significantly, with a registered user base exceeding 300,000 by early 2012. The company operates primarily within the online content community space, monetizing its services through a combination of paid memberships, advertising, content-commerce solutions, and vocational training offerings. All of its revenue is generated from within China, reflecting its focus on the domestic market and its commitment to providing users with a rich and engaging platform for knowledge sharing.
Meican.com is a prominent online platform that specializes in food catering and delivery services. Established in January 2011, it operates in major cities such as Beijing, Shanghai, Guangzhou, and Shenzhen, partnering with over 30,000 restaurants to offer a diverse range of meal options. The platform facilitates mobile ordering and provides detailed take-out menus, catering to the needs of both individual users and enterprises. For businesses, Meican.com streamlines meal ordering processes, offering solutions for food classification and settlement, allowing companies to focus on their core operations. With a strong emphasis on product research and development, Meican.com leverages its experienced team to enhance both online and offline services, ensuring a convenient and personalized dining experience.
Carzone
Private Equity Round in 2018
Jiangsu Kangzhong Shiye Investment operates a retail chain, Carzone, that deals in and retails automotive post-market parts. The company was founded in 1995 and is based in Nanjing, China.
Megvii, founded in 2011, is an artificial intelligence company that specializes in intelligent solutions and data services for enterprises and developers. The company is focused on its mission to create machines capable of seeing and thinking, leveraging its deep learning system, Brain++. Megvii aims to build a comprehensive AI engine that serves as the foundational technology for various applications. It connects standardized hardware, such as sensors and personal devices, with artificial intelligence and the Internet of Things (AIoT), commercializing three main application areas: Consumer IoT, City IoT, and Supply Chain IoT. By integrating hardware and software solutions, Megvii enables clients to efficiently establish AI infrastructure tailored to their needs, positioning itself as an expert in AIoT solutions.
DoBe Group
Series B in 2017
DoBe Group, established in Shanghai, China in 2006, specializes in developing and operating real estate properties tailored for cultural and creative industries. The company serves as a professional operator of creative office parks, offering comfortable workspaces alongside comprehensive services to facilitate the growth of cultural and creative enterprises. Additionally, DoBe Group provides enterprise management services, brand promotion services, and financial consulting services to support its tenants' development.
Kangfu Zhijia
Series D in 2016
Kangfu Zhijia is an omni-channel service provider of household medical equipment.
QuantGroup
Series C in 2016
Founded in 2014, QuantGroup is a data-driven financial services platform dedicated to enhancing traditional industries through advanced technology. The company specializes in providing scenario-based digital empowerment services that leverage artificial intelligence to integrate various aspects of business operations, including technology, traffic, and goods and services. With a commitment to independent research and development, QuantGroup offers tailored marketing solutions and financial technology integration services aimed at both consumers and financial institutions. Its mission centers on utilizing data to facilitate convenient and efficient services, ultimately striving to transform how businesses operate in the digital landscape.
Orbiepharm
Series C in 2016
Orbiepharm is a pharmaceutical manufacturing company specializing in the veterinary industry. It develops and produces a range of products aimed at improving animal health, including solid preparations, ointments, insecticides, inhalational anesthetics, and oral solvents. The company's focus encompasses various therapeutic areas related to common, medical, chronic, and geriatric diseases in pets. Orbiepharm distinguishes itself by being the only comprehensive pet medicine and health enterprise in China that integrates research and development, production, sales, and terminal hospitals, thereby enhancing the efficiency of diagnosis and treatment for animals.
Zhongguo Qiye Bao
Angel Round in 2010
Zhongguo Qiye Bao is a newspaper publishing company.